Interactive role of trauma cytokines and erythropoietin and their therapeutic potential for acute and chronic wounds

Rejuvenation Research

Volumn 14, Issue 1, 2011, Pages 57-66

  Bader, Augustinus ^a   Lorenz, Katrin ^a   Richter, Anja ^a   Scheffler, Katja ^a   Kern, Larissa ^a   Ebert, Sabine ^a   Giri, Shibashish ^a   Behrens, Maria ^b   Dornseifer, Ulf ^c   MacChiarini, Paolo ^d   MacHens, Hans Günther ^e  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Medical Writing Experts ^*  (Germany)

^c KLINIKUM BOGENHAUSEN   (Germany)

^d HOSPITAL CLÍNIC   (Spain)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ENDOGLIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; RECOMBINANT ERYTHROPOIETIN; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; CHILD; DEBRIDEMENT; DECUBITUS; EPITHELIZATION; FEMALE; GRANULATION TISSUE; HUMAN; HUMAN CELL; HYDROGEL; LEG ULCER; MALE; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TRANSPLANTATION; STEM CELL; WOUND; WOUND CARE; WOUND DRESSING; WOUND HEALING;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; CHILD, PRESCHOOL; CHRONIC DISEASE; CYTOKINES; DERMIS; DRUG SYNERGISM; ERYTHROPOIETIN; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, ERYTHROPOIETIN; SEQUENCE ANALYSIS, PROTEIN; STEM CELLS; WOUNDS AND INJURIES;

EID: 79951843059     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2010.1050     Document Type: Article

References (68)

1. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-746. (Pubitemid 29407375)
2. Müller T, Ander L, Kolf K, Woitalla D, Muhlack S. Comparison of 200mg retarded release levodopa/carbidopa with 150mg levodopa/carbidopa/ entacapone application: Pharmacokinetics and efficacy in patients with Parkinson's disease. J Neural Transm 2007;114:1457-1462. (Pubitemid 350112288)
3. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: Characteristics and clinical applications. Folia Histochem Cytobiol 2006;44:215-230. (Pubitemid 44696963)
4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
5. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295. (Pubitemid 35471185)
6. Hauner H, Schmid P, Pfeiffer EF. Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab 1987;64:832-835. (Pubitemid 17044555)
7. Grigoriadis AE, Heersche JN, Aubin JE. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexa-methasone. J Cell Biol 1988;106:2139-2151.
8. Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995;18: 1417-1426.
9. Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001;3:778-784. (Pubitemid 32842682)
10. Crigler L, Kazhanie A, Yoon TJ, Zakhari J, Anders J, Taylor B, Virador VM. Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages. FASEB J 2007;21:2050-2063. (Pubitemid 47026441)
11. Toma JG, Akhavan M, Fernandes KJ, Barnabe-Heider F, Sadikot A, Kaplan DR, Miller FD. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 2001;3:778-784. (Pubitemid 32842682)
12. French MM, Rose S, Canseco J, Athanasiou KA. Chondro-genic differentiation of adult dermal fibroblasts. Ann Biomed Eng 2004;32:50-56.
13. Hirata K, Tsukazaki T, Kadowaki A, Furukawa K, Shibata Y, Moriishi T, Okubo Y, Bessho K, Komori T, Mizuno A, Ya-maguchi A. Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 2001;32:502-512. (Pubitemid 39665709)
14. Krebsbach PH, Gu K, Franceschi RT, Rutherford RB. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 2000;11:1201-1210. (Pubitemid 30331585)
15. Rutherford RB, Moalli M, Franseschi RT, Wang D, Gu K, Krebsbach PH. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng 2002;8:441-452. (Pubitemid 34747801)
16. Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM. Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation. Hepatology 2007;46:1574-1585. (Pubitemid 350155539)
17. Chen FG, Zhang WJ, Bi D, Liu W, Wei X, Chen FF, Zhu L, CuiL, Cao Y. Clonal analysis of nestin(- ) vimentin(+) multipotent fibroblasts isolated from human dermis. J Cell Sci 2007;120:2875-2883. (Pubitemid 47394261)
18. Toma, JG, McKenzie IA, Bagli D, Miller FD. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 2005;23:727-737. (Pubitemid 40791788)
19. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-228. (Pubitemid 32295155)
20. Lorenz K, Sicker M, Schmelzer E, Rupf T, Salvetter J, Schulz-Siegmund M, Bader A. Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol 2008b;17:925-932.
21. Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003;139:510-516. (Pubitemid 36427615)
22. Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y. Survival and proliferative roles of erythropoietin beyond the ery-throid lineage. Expert Rev Mol Med 2008;1:36.
23. Amarguellat F, Gogusev J, and Drueke TB. Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant 1996;11:687-692. (Pubitemid 26114553)
24. Alvarez Arroyo MV, Castilla MA, Gonzalez Pacheco FR, Tan D, Riesco A, Casado S, Caramelo C. Role of vascular endothelial growth factor on erythropoietinrelated endothelial cell proliferation. J Am Soc Nephrol 1998;9:1998-2004. (Pubitemid 28482147)
25. Buemi M, Marino D, Floccari F, Ruello A, Nostro L, Aloisi C, Marino MT, Di Pasquale G, Corica F, Frisina N. Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension. Curr Med Res Opin 2004;20:19-24. (Pubitemid 38063450)
26. Buemi M, Vaccaro M, Sturiale A, Galeano MR, Sansotta C, Cavallari V, Floccari F, D'Amico F, Torre V, Calapai G, Frisina N, Guarneri F, Vermiglio G. Recombinant human erythropoietin influences revascularization and healing in a rat model of random ischaemic flaps. Acta Derm Venereol 2002;82:411-417. (Pubitemid 36140240)
27. Vaccaro M, Magaudda L, Cutroneo G, Trimarchi F, Barbuzza O, Guarneri B. Changes in the distribution of laminin a1 chain in psoriatic skin. Immunohistochemical study using confocal laser scanning microscopy Br J Dermatol 2002;146:392-398. (Pubitemid 34603810)
28. Bennett CL, Silver SM, Djulbegovic B, Samaras AT, Blau CA, Gleanson KJ, Barnato SE, Elvermann KM, Courtney DM, McKoy JM, Edwards BJ, Tigue CC, Raisch DW, Yarnold PR, Dorr DA, Kuzel TM, Tallman MS, Trifilio SM, West DP, Lai SY, Henke M. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA 2008;299:914-924. (Pubitemid 351397066)
29. Ponec M, Weerheim A, Kempenaar J, Mommaas AM, Nugteren DH. Lipid composition of cultured human kera-tinocytes in relation to their differentiation. J Lipid Res 1988;29:949-61.
30. Brouty-Boye D, Raux H, Azzarone B, Tamboise A, Tamboise E, Beranger S, Magnien V, Pihan I, Zardi L, Israel L. Fetal myofibroblast-like cells isolatedfrom post-radiation fibrosis in human breast cancer. Int J Cancer 1991;47:697-702.
31. Jelkmann W, Bohlius J, Hallek M, Sytkowski AJ. The erythropoietin receptor in normal and cancer tissues. Critical Review on Oncology and Hematology 2008;67:39-61.
32. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B, Epoietin Alpha Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-2874. (Pubitemid 32538196)
33. Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide syn-thase. Cardiovasc Res 2006;72:51-59. (Pubitemid 44310637)
34. Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M. Recombinant human eryth-ropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 2003;100:4802-4806. (Pubitemid 36457809)
35. Moon C, Krawczky M, Ahn D, Ahmet I, Paik K, Lakatta EG, Talan MI. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 2003;100:11612-11617. (Pubitemid 37205984)
36. Rui T, Cepinskas G, Feng Q, Kvietys PR. Delayed preconditioning in cardiac myocytes with respect to development of a proinflammatory phenotype: Role of SOD and NOS. Cardiovasc Res 2003;59:901-911. (Pubitemid 38366246)
37. Tada H, Kagaya Y, Takeda M, Ohta J, Asaumi Y, Satoh K, Ito K, Karibe A, Shirato K, Minegishi N, Shimokawa H. Endogenous erythropoietin system in non-hematopoietic lineage cells play a protective role in myocardial ischemia/ reperfusion. Cardiovasc Res 2006;71:466-477. (Pubitemid 44107864)
38. Bienvenu AL, Ferrandiz J, Kaiser K, Latour C, Picot S. Ar-tesunateerythropoietin combination for murine cerebral malaria treatment Acta Trop 2008;106:104-108.
39. Digicaylioglu M, Lipton SA, Erythropoietin-mediated neu-roprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001;412:601-602.
40. Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, Smith LE. Supression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci 2009;50:1329-1335.
41. Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O, Kawauchi S, Ema M, Shibahara S, Udono T, Tomita K, Tamai M, Sogawa K, Yamamoto M, Fujii-Kuriyama Y. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J 2003;22:1134-1146. (Pubitemid 36313597)
42. Friedman EA, Brown CD, Berman DH. Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 1995;26:202-208.
43. Lee IG, Chae SL, Kim JC. Involvement of circulating endo-thelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye 2006;20:546-552. (Pubitemid 43674990)
44. Tong Z, Yang Z, Patel S, Chen H, Gibbs D, Yang X, Hau VS, Kaminoh Y, Harmon J, Pearson E, Buehler J, Chen Y, Yu B, Tinkham NH, Zabriskie NA, Zeng J, Luo L, Sun JK, Prakash M, Hamam RN, Tonna S, Constantine R, Ronquillo CC, Sadda S, Avery RL, Brand JM, London N, Anduze AL, King GL, Bernstein PS, Watkins S, Genetics of Diabetes and Diabetic Complication Study Group, Jorde LB, Li DY, Aiello LP, Pollak MR, Zhang K. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci USA 2008;105:6998-7003. (Pubitemid 351754519)
45. Manzoni P, Maestri A, Gomirato G, Takagi H, Watanabe D, Matsui S. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005;353: 782-792. (Pubitemid 41215487)
46. Holstein JH, Menger MD, Scheuer C, Meier C, Culemann U, Wirbel RJ, Garcia P, Pohlemann T. Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci 2007;80:893-900. (Pubitemid 46186418)
47. Gough NR. Making Sense of EPO Receptors. Science 2008; 320:1397
48. Foster DJ, Moe OW, Hsia CCW Upregulation of erythro-poietin receptor during postnatal and postpneumonectomy lung growth. Am J Physiol 2004;287:L1107-L1115. (Pubitemid 39507186)
49. Brines M, Cerami A. Emerging boilogicala roles for eryth-ropoietin in the nervous system. Nat l Rev Neurosci 2005; 6:484-894.
50. Bodó E, Kromminga A, Funk W, Laugsch M, Duske U, Jelkmann W, Paus R. Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin. FASEB J 2007;21:3346-3354. (Pubitemid 47565553)
51. Paus R, Bodó E, Kromminga A, Jelkmann W. Erythropoietin and the skin: A role for epidermal oxygen sensing? Bioes-says 2009;31:344-348.
52. Ito M, Liu Y, Yang Z, Nguyen J, Liang F, Morris RJ, Cotsarelis G. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis ofthe epidermis. Nature Med 2005;11:1351-1354. (Pubitemid 41752917)
53. Maxwell PH, Ferguson DJ, Nicholls LG, Johnson MH, Ratcliffe PJ. Theinterstitial response to renal injury: Fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 1997;52:715-724. (Pubitemid 27402371)
54. Boutin AT, Weidemann A, Fu Z, Mesropian L, Gradin K, Jamora C, Wiesener M, Eckardt KU, Koch CJ, Ellies LG, Haddad G, Haase VH, Simon MC, Poellinger L, Powell FL, Johnson RS. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008;133:223-234. (Pubitemid 351508305)
55. Köchling J, Curtin PT, Madan A. Regulation of human erythropoietin gene induction by upstream flanking sequences in transgenic mice. Br J Haematol 1998;103:960-968. (Pubitemid 29012631)
56. Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol 1995;132:79-85.
57. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053. (Pubitemid 38579764)
58. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007;117:1219-1222. (Pubitemid 46718408)
59. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005;366:1736-1743. (Pubitemid 41587454)
60. Langer A, Rogowski W.Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res 2009;9:115.
61. Hanft JR, Surprenant MS. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg 2002;41:291-299. (Pubitemid 35176267)
62. Hjerppe A, Hjerppe M, Autio V, Raudasoja R, Vaalasti A. Treatment of chronic leg ulcers with a human fibroblast-derived dermal substitute: A case series of 114 patients. Wounds 2004;16(3), Health Management Publications, Inc.
63. Brines M, Cerami A.Erythropoietin-mediated tissue protection: Reducing collateral damage from the primary injury response. J Intern Med 2008;264:405-432.
64. Hamed S, Ullmann Y, Masoud M, Hellou E, Khamaysi Z, Teot L. Topical erythropoietin promotes wound repair in diabetic rats. J Invest Dermatol 2010;130287-130294.
65. Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macro-phages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988;241:708-712.
66. Mikhal'chik EV, Piterskaya JA, Budkevich LY, Pen'kov LY, Facchiano A, De Luca C, Ibragimova GA, Korkina LG.Comparative study of cytokine content in the plasma and wound exudate from children with severe burns, Bull Exp Biol Med, 2009, 148, 771-775.
67. Rezaeian F, Wettstein R, Amon M, Scheuer C, Schramm R, Menger MD, Pittet B, Harder Y. Erythropoietin protects critically perfused flap tissue. Ann Surg 2008;248:919-929.
68. Galeano M, Altavilla D, Cucinotta D, Russo GT, Calò M, Bitto A, Marini H, Marini R, Adamo EB, Seminara P, Minutoli L, Torre V, Squadrito F. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004;53:2509-2517. (Pubitemid 39145612)